<DOC>
	<DOCNO>NCT02720991</DOCNO>
	<brief_summary>A pilot study acceptability feasibility Mifepristone 400 mg sub-lingual Misoprostol 71-77 78-84 day gestation 50 case .</brief_summary>
	<brief_title>A Pilot Outpatient Regimen Medical Abortion With Mifepristone Sublingual Misoprostol 11 12 Weeks</brief_title>
	<detailed_description>The study enroll 25 woman gestational age group . All participant submit routine screening per current practice La Rabta Hospital . The eligible woman receive dose 200 mg mifepristone 400 ug misoprostol take home sublingually . The first 5 woman enrol gestational age group ask return clinic 24-48 hour initial visit take misoprostol clinic wait 3 hour observational period return home . After initial phase , woman ask self-administer misoprostol home 24-48 hour administration mifepristone return clinic 7-10 day later . At follow-up , healthcare provider assure medical abortion complete ask woman respond series question exit interview .</detailed_description>
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Gestational age 7184 day amenorrhea Seeking abortion service Prepared able sign consent form Accept conform study procedure schedule visit Does meet study criterion</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>